The FDA should strengthen the evidence required for the approval of drugs under its accelerated pathway and increase the ...
Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. | ...
Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...
The Biotechnology Innovation Organization (BIO) has started the nationwide “The Fight of Our Lives” campaign, creating a ...
Healthcare technology company Verily Health has kicked off its first major national campaign, the latest step in a mission to ...
Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...
Viatris and Teva Pharmaceutical Industries recently launched separate recalls in the U.S. related to dissolution problems for ...
The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary ...
Roche is launching a new global phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in ...
Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as Olixir New York ...
The FDA’s Pharmacy Compounding Advisory Committee will meet this summer to discuss whether certain peptides from compounding ...
Actress, producer, and artist Lucy Liu has joined Pfizer’s mission to deliver a knockout blow against cancer, becoming the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results